-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
David J. Schlanger Sells 41,667 Shares of Progyny, Inc. (NASDAQ:PGNY) Stock
David J. Schlanger Sells 41,667 Shares of Progyny, Inc. (NASDAQ:PGNY) Stock
Progyny, Inc. (NASDAQ:PGNY – Get Rating) Chairman David J. Schlanger sold 41,667 shares of the firm's stock in a transaction that occurred on Tuesday, August 9th. The stock was sold at an average price of $41.65, for a total transaction of $1,735,430.55. Following the sale, the chairman now owns 82,548 shares of the company's stock, valued at $3,438,124.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
Progyny Stock Performance
Shares of NASDAQ:PGNY opened at $44.32 on Friday. The company has a market cap of $4.08 billion, a PE ratio of 96.35, a price-to-earnings-growth ratio of 11.08 and a beta of 1.85. Progyny, Inc. has a 52 week low of $25.67 and a 52 week high of $68.32. The firm has a 50 day simple moving average of $31.18 and a 200 day simple moving average of $37.49.
Get Progyny alerts:Progyny (NASDAQ:PGNY – Get Rating) last issued its quarterly earnings results on Thursday, August 4th. The company reported $0.09 EPS for the quarter, beating the consensus estimate of $0.05 by $0.04. The business had revenue of $195.00 million during the quarter, compared to the consensus estimate of $190.51 million. Progyny had a net margin of 7.39% and a return on equity of 17.11%. The firm's quarterly revenue was up 51.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.19 EPS. On average, equities analysts predict that Progyny, Inc. will post 0.18 earnings per share for the current year.
Institutional Investors Weigh In On Progyny
Hedge funds have recently made changes to their positions in the company. American Century Companies Inc. lifted its position in Progyny by 407.4% in the 4th quarter. American Century Companies Inc. now owns 2,323,001 shares of the company's stock worth $116,963,000 after buying an additional 1,865,151 shares in the last quarter. Baillie Gifford & Co. lifted its position in Progyny by 337,578.8% in the 1st quarter. Baillie Gifford & Co. now owns 1,337,208 shares of the company's stock worth $68,732,000 after buying an additional 1,336,812 shares in the last quarter. Riverbridge Partners LLC lifted its position in Progyny by 87.7% in the 1st quarter. Riverbridge Partners LLC now owns 1,525,055 shares of the company's stock worth $78,388,000 after buying an additional 712,722 shares in the last quarter. Wafra Inc. lifted its position in Progyny by 64.1% in the 1st quarter. Wafra Inc. now owns 1,252,197 shares of the company's stock worth $64,363,000 after buying an additional 489,179 shares in the last quarter. Finally, Clearbridge Investments LLC lifted its position in Progyny by 13.3% in the 2nd quarter. Clearbridge Investments LLC now owns 3,652,887 shares of the company's stock worth $106,116,000 after buying an additional 429,385 shares in the last quarter. Hedge funds and other institutional investors own 82.51% of the company's stock.Progyny Company Profile
(Get Rating)
Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.
Read More
- Get a free copy of the StockNews.com research report on Progyny (PGNY)
- Look at Honeywell for a Steady and Diversified Stock
- Why Invest in High-Yield Dividend Stocks?
- Find and Profitably Trade Stocks at 52-Week Lows
- Disney (NYSE: DIS) Shares Just Gave Investors A Massive Signal
- Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
Receive News & Ratings for Progyny Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Progyny and related companies with MarketBeat.com's FREE daily email newsletter.
Progyny, Inc. (NASDAQ:PGNY – Get Rating) Chairman David J. Schlanger sold 41,667 shares of the firm's stock in a transaction that occurred on Tuesday, August 9th. The stock was sold at an average price of $41.65, for a total transaction of $1,735,430.55. Following the sale, the chairman now owns 82,548 shares of the company's stock, valued at $3,438,124.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
纳斯达克(股票代码：PGNY-GET Rating)董事长施兰格在8月9日星期二的交易中出售了41,667股该公司股票。该股的平均售价为41.65美元，总成交金额为1,735,430.55美元。出售后，董事长现在拥有82,548股公司股票，价值3,438,124.20美元。这笔交易是在提交给美国证券交易委员会(Securities&Exchange Commission)的一份文件中披露的，可以通过这个链接访问。
Progyny Stock Performance
Progyny股票表现
Shares of NASDAQ:PGNY opened at $44.32 on Friday. The company has a market cap of $4.08 billion, a PE ratio of 96.35, a price-to-earnings-growth ratio of 11.08 and a beta of 1.85. Progyny, Inc. has a 52 week low of $25.67 and a 52 week high of $68.32. The firm has a 50 day simple moving average of $31.18 and a 200 day simple moving average of $37.49.
纳斯达克：PGNY上周五开盘报44.32美元。该公司市值为40.8亿美元，市盈率为96.35倍，市盈率为11.08倍，贝塔系数为1.85。Progyny，Inc.的52周低点为25.67美元，52周高点为68.32美元。该公司的50日简单移动均线切入位为31.18美元，200日简单移动均线切入位为37.49美元。
Progyny (NASDAQ:PGNY – Get Rating) last issued its quarterly earnings results on Thursday, August 4th. The company reported $0.09 EPS for the quarter, beating the consensus estimate of $0.05 by $0.04. The business had revenue of $195.00 million during the quarter, compared to the consensus estimate of $190.51 million. Progyny had a net margin of 7.39% and a return on equity of 17.11%. The firm's quarterly revenue was up 51.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.19 EPS. On average, equities analysts predict that Progyny, Inc. will post 0.18 earnings per share for the current year.
纳斯达克上一次发布季度收益报告是在8月4日星期四。该公司公布本季度每股收益为0.09美元，比普遍预期的0.05美元高出0.04美元。该业务本季度的收入为1.95亿美元，而普遍预期为1.905亿美元。Progyny的净利润率为7.39%，股本回报率为17.11%。该公司季度营收同比增长51.5%。去年同期，该公司每股收益为0.19美元。股票分析师平均预测，Progyny，Inc.本年度每股收益将为0.18美元。
Institutional Investors Weigh In On Progyny
机构投资者对Progyny的看法
Progyny Company Profile
Progyny公司简介
(Get Rating)
(获取评级)
Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.
Progyny，Inc.是一家福利管理公司，专门为美国雇主提供生育和家庭建设福利解决方案。其生育福利解决方案包括差异化福利计划设计、个性化礼宾式会员支持服务和有选择的生育专家网络。
Read More
阅读更多内容
- Get a free copy of the StockNews.com research report on Progyny (PGNY)
- Look at Honeywell for a Steady and Diversified Stock
- Why Invest in High-Yield Dividend Stocks?
- Find and Profitably Trade Stocks at 52-Week Lows
- Disney (NYSE: DIS) Shares Just Gave Investors A Massive Signal
- Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
- 免费获取StockNews.com关于Progyny的研究报告(PGNY)
- 霍尼韦尔看好稳定和多元化的股票
- 为什么要投资高收益股利股票？
- 找到并获利于52周低点的股票交易
- 迪士尼(NYSE：DIS)的股票刚刚给了投资者一个巨大的信号
- 清洁能源法案通过后，太阳能股大放异彩
Receive News & Ratings for Progyny Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Progyny and related companies with MarketBeat.com's FREE daily email newsletter.
接受Progyny Daily的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Progyny和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧